By Stephen Nakrosis
Shares of LifeMD were trading in the green in the after-hours session following the release of fourth-quarter financial results that topped some analysts' estimates and the release of 2025 guidance.
After the bell, the company's shares were trading 24% higher, at $5.31. The stock ended Monday's regular session with an 8.5% loss, closing at $4.27.
LifeMD reported a fourth-quarter loss per share of 2 cents. Analysts were expecting a loss of 5 cents per share, according to FactSet. Revenue for the fourth quarter came in at $64.3 million. Analysts had expected revenue of $57.5 million, according to FactSet.
On an adjusted basis, LifeMD reported fourth-quarter earnings per share of 21 cents.
For full year 2024, the telehealth company reported revenue of $212.5 million. LifeMD said it was expecting 2025 revenue in a range of $265 million to $275 million, and first-quarter revenue of $61 million to $63 million.
Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
March 10, 2025 17:37 ET (21:37 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。